title: miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.
abstract: Oncogenic fusion proteins belong to an important class that disrupts gene expression networks in a cell. Astonishingly, fusion-positive prostate cancer cells enable the multi-gene regulatory capability of miRNAs to remodel the signal transduction landscape, enhancing or antagonizing the transmission of information to downstream effectors. Accumulating evidence substantiates the fact that miRNAs translate into dose-dependent responsiveness of cells to signaling regulators in transmembrane protease serine 2:ETS-related gene (TMPRSS2-ERG)-positive cells. Wide ranging signaling proteins are the targets for the degree of quantitative fluctuations imposed by miRNAs. miRNA signatures are aberrantly expressed in fusion-positive cancer cells, suggesting that they have a cumulative effect on tumor aggressiveness. It seems attractive to note that TMPRSS2:ERG fusion has a stronger effect as tumors positive for the oncogenic TMPRSS2:ERG have dysregulated oncomirs and tumor suppressor miRNA signature. It is undeniable that a comprehensive analysis of the prostate cancer microRNAome is necessary to uncover novel microRNAs and pathways associated with prostate cancer. Moreover, the identification and validation of miRNA signature in TMPRSS2-ERG-positive prostate cancer cells may help to identify novel molecular targets and pathways for personalized therapy.
authors.affiliation: Laboratory for Translational Oncology and Personalized Medicine, Rashid Latif Medical College, Lahore, Pakistan.
authors.forename: Sundas
authors.initials: S
authors.lastname: Fayyaz
authors.forename: Ammad Ahmad
authors.initials: AA
authors.lastname: Farooqi
mesh_terms: D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011471:Prostatic Neoplasms / Q000235:genetics*
chemical_list: D035683:MicroRNAs; D015514:Oncogene Proteins, Fusion; C515553:TMPRSS2-ERG fusion protein, human
references.citation: Hepatology. 2012 Jan;55(1):98-107
references.pmid: 21887698
references.citation: Anticancer Res. 2011 Feb;31(2):403-10
references.pmid: 21378318
references.citation: PLoS One. 2012;7(10):e47454
references.pmid: 23077621
references.citation: PLoS Genet. 2009 Oct;5(10):e1000697
references.pmid: 19851444
references.citation: J Biol Chem. 2009 Nov 13;284(46):31921-7
references.pmid: 19723635
references.citation: Cancer Res. 2001 Mar 1;61(5):2112-8
references.pmid: 11280774
references.citation: PLoS One. 2012;7(2):e30590
references.pmid: 22363450
references.citation: Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E927-31
references.pmid: 14761877
references.citation: Oncogene. 2012 Jan 12;31(2):226-37
references.pmid: 21666718
references.citation: Mol Cell. 2005 Mar 4;17(5):709-20
references.pmid: 15749020
references.citation: PLoS One. 2011;6(10):e26539
references.pmid: 22039506
references.citation: Mol Cancer. 2010 Mar 10;9:55
references.pmid: 20219091
references.citation: J Clin Endocrinol Metab. 2012 Sep;97(9):3292-301
references.pmid: 22730517
references.citation: Cell Biosci. 2011 Jan 18;1(1):4
references.pmid: 21711587
references.citation: Free Radic Biol Med. 2011 Jul 1;51(1):78-87
references.pmid: 21539911
references.citation: Epigenetics. 2012 Aug;7(8):940-9
references.pmid: 22805767
references.citation: Int J Cancer. 2012 Aug 1;131(3):652-61
references.pmid: 22052531
references.citation: J Immunol. 2011 Dec 15;187(12):6171-5
references.pmid: 22084432
references.citation: Carcinogenesis. 2012 Nov;33(11):2276-82
references.pmid: 22871495
references.citation: Oncogene. 2012 Oct 11;31(41):4460-71
references.pmid: 22266859
references.citation: Cancer Gene Ther. 2009 Mar;16(3):206-16
references.pmid: 18949015
references.citation: Nucleic Acids Res. 2011 May;39(9):3892-902
references.pmid: 21245048
references.citation: BMC Cancer. 2012 Mar 30;12:130
references.pmid: 22462810
references.citation: J Exp Med. 2008 Sep 29;205(10):2199-206
references.pmid: 18762567
references.citation: Int J Cancer. 2010 Mar 1;126(5):1166-76
references.pmid: 19676045
references.citation: Radiol Oncol. 2012 Sep;46(3):233-41
references.pmid: 23077462
references.citation: Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12561-6
references.pmid: 15314219
references.citation: Carcinogenesis. 2012 Jan;33(1):41-8
references.pmid: 22049531
references.citation: Am J Blood Res. 2012;2(1):71-6
references.pmid: 22432090
references.citation: Mol Cell Biol. 2011 Sep;31(18):3790-801
references.pmid: 21768308
references.citation: BMC Res Notes. 2012 Mar 27;5:164
references.pmid: 22452920
references.citation: Mol Pharmacol. 2011 Apr;79(4):735-41
references.pmid: 21252292
references.citation: PLoS One. 2009;4(3):e4998
references.pmid: 19308264
references.citation: PLoS One. 2012;7(3):e33778
references.pmid: 22457788
references.citation: J Neurosci. 2011 Oct 26;31(43):15407-15
references.pmid: 22031887
references.citation: Cancer Res. 2009 Apr 15;69(8):3356-63
references.pmid: 19351832
references.citation: Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19397-402
references.pmid: 23132946
references.citation: Cell Death Differ. 2011 Oct;18(10):1628-39
references.pmid: 21527937
references.citation: J Biol Chem. 2012 Jan 2;287(1):465-473
references.pmid: 22074923
references.citation: Free Radic Biol Med. 2012 May 1;52(9):1508-18
references.pmid: 22387281
references.citation: Leuk Res. 2012 Jul;36(7):905-11
references.pmid: 22424712
references.citation: J Am Soc Nephrol. 2011 Jul;22(7):1252-61
references.pmid: 21719785
references.citation: BMC Cancer. 2011 Dec 05;11:507
references.pmid: 22142399
references.citation: Nat Cell Biol. 2010 Mar;12(3):235-46
references.pmid: 20173741
references.citation: Prostate Cancer Prostatic Dis. 2010 Dec;13(4):356-61
references.pmid: 20820187
references.citation: PLoS One. 2012;7(9):e44206
references.pmid: 22962603
references.citation: Br J Cancer. 2009 Apr 7;100(7):1165-74
references.pmid: 19277043
references.citation: PLoS Genet. 2009 Jun;5(6):e1000524
references.pmid: 19543365
references.citation: BMC Cell Biol. 2008 Jan 24;9:4
references.pmid: 18218096
references.citation: Carcinogenesis. 2012 Jan;33(1):68-76
references.pmid: 22072622
references.citation: Anticancer Res. 2012 Sep;32(9):3629-41
references.pmid: 22993300
references.citation: Front Genet. 2011 Sep 06;2:62
references.pmid: 22303357
references.citation: Mol Cells. 2012 Jun;33(6):545-51
references.pmid: 22684895
references.citation: Cancer Res. 2010 Jun 1;70(11):4560-8
references.pmid: 20460526
references.citation: Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9747-52
references.pmid: 17535927
references.citation: Cell Tissue Res. 2011 Dec;346(3):383-91
references.pmid: 22160459
references.citation: J Inorg Biochem. 2011 Nov;105(11):1434-7
references.pmid: 22099153
references.citation: EMBO J. 2011 Feb 16;30(4):770-82
references.pmid: 21224848
references.citation: Mol Cancer. 2010 Apr 26;9:89
references.pmid: 20420697
references.citation: BMC Genomics. 2011 Jan 21;12:54
references.pmid: 21255435
references.citation: Oncogene. 2012 Sep 13;31(37):4150-63
references.pmid: 22158050
references.citation: Technol Cancer Res Treat. 2010 Apr;9(2):123-38
references.pmid: 20218735
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
references.pmid: 16461460
references.citation: Mol Cancer Res. 2011 Aug;9(8):1100-11
references.pmid: 21693595
references.citation: Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):E309-16
references.pmid: 22223664
references.citation: Antioxid Redox Signal. 2013 Apr 1;18(10):1129-40
references.pmid: 22998676
references.citation: PLoS One. 2010 Jun 21;5(6):e10748
references.pmid: 20574517
references.citation: J Neurosci. 2009 Dec 2;29(48):15161-8
references.pmid: 19955368
references.citation: Prostate. 2012 Jul 1;72(10):1093-103
references.pmid: 22127852
references.citation: J Biol Chem. 2011 Aug 12;286(32):28312-21
references.pmid: 21685392
references.citation: Cancer Prev Res (Phila). 2011 Jan;4(1):76-86
references.pmid: 21071579
references.citation: Cancer Biol Ther. 2011 May 15;11(10):902-9
references.pmid: 21386657
references.citation: Gastroenterology. 2012 Jul;143(1):246-56.e8
references.pmid: 22484120
references.citation: Oncogene. 2011 Mar 3;30(9):1082-97
references.pmid: 21057537
references.citation: EMBO J. 2007 Jan 24;26(2):346-57
references.pmid: 17183365
references.citation: Oncol Rep. 2012 Mar;27(3):685-94
references.pmid: 22134529
references.citation: Oncogene. 2011 Apr 28;30(17):2044-56
references.pmid: 21242973
references.citation: Cancer Res. 2010 Sep 1;70(17):6735-45
references.pmid: 20713528
references.citation: Curr Biol. 2002 Mar 5;12(5):397-402
references.pmid: 11882291
references.citation: Biochem Biophys Res Commun. 2012 Apr 20;420(4):787-92
references.pmid: 22459450
references.citation: Cancer Cell. 2007 Nov;12(5):457-66
references.pmid: 17996649
references.citation: Nat Rev Cancer. 2008 Jul;8(7):497-511
references.pmid: 18563191
references.citation: Cell Signal. 2012 Dec;24(12):2291-6
references.pmid: 22820499
references.citation: Neuro Oncol. 2012 May;14(5):596-612
references.pmid: 22411914
references.citation: Oncogene. 2011 Apr 21;30(16):1868-79
references.pmid: 21151173
references.citation: Endocrinology. 1998 Aug;139(8):3569-77
references.pmid: 9681509
references.citation: BMC Cancer. 2011 Aug 10;11:347
references.pmid: 21831295
references.citation: Prostate. 2013 Jan;73(1):101-12
references.pmid: 22674191
references.citation: Oncogene. 2010 Jan 14;29(2):237-50
references.pmid: 19802001
references.citation: Mol Endocrinol. 2011 Oct;25(10):1677-88
references.pmid: 21885566
references.citation: Mutagenesis. 2012 Jul;27(4):463-9
references.pmid: 22379123
references.citation: J Biol Chem. 2002 Nov 15;277(46):43749-56
references.pmid: 12226080
references.citation: PLoS One. 2011;6(12):e29094
references.pmid: 22194996
references.citation: Cancer Res. 2009 Apr 15;69(8):3249-55
references.pmid: 19351822
references.citation: J Clin Invest. 2011 Apr;121(4):1373-85
references.pmid: 21403400
references.citation: Cancer Res. 2012 Apr 1;72(7):1751-62
references.pmid: 22350414
references.citation: Cancer Res. 2011 Sep 1;71(17):5659-69
references.pmid: 21693658
references.citation: PLoS One. 2012;7(3):e32832
references.pmid: 22479342
references.citation: PLoS One. 2012;7(2):e30771
references.pmid: 22363487
references.citation: J Hum Genet. 2012 Nov 26;57(11):691-9
references.pmid: 22854542
references.citation: PLoS One. 2012;7(1):e29541
references.pmid: 22235305
references.citation: Cancer Sci. 2007 Dec;98(12):1845-52
references.pmid: 17888029
references.citation: Cell Death Differ. 2010 Mar;17(3):452-8
references.pmid: 19960022
references.citation: Cancer Res. 2011 Feb 15;71(4):1442-53
references.pmid: 21169410
references.citation: PLoS One. 2011;6(10):e24429
references.pmid: 22022355
references.citation: PLoS One. 2010 Mar 03;5(3):e9485
references.pmid: 20209130
references.citation: Cancer Res. 2009 Sep 15;69(18):7366-74
references.pmid: 19738062
references.citation: J Biol Chem. 2002 Jan 11;277(2):1240-8
references.pmid: 11707452
references.citation: Biochem Biophys Res Commun. 2011 Jan 21;404(3):809-15
references.pmid: 21172305
references.citation: Mol Cancer Res. 2009 Sep;7(9):1543-52
references.pmid: 19737972
references.citation: J Biol Chem. 2012 Sep 28;287(40):33594-606
references.pmid: 22865883
references.citation: Blood. 2011 Jun 30;117(26):7053-62
references.pmid: 21551231
references.citation: PLoS One. 2008;3(12):e4029
references.pmid: 19107213
references.citation: EMBO J. 2008 Oct 8;27(19):2616-27
references.pmid: 18756266
references.citation: Nat Med. 2011 Nov 20;17(12):1627-35
references.pmid: 22101765
references.citation: J Bone Miner Res. 2009 Jul;24(7):1180-93
references.pmid: 19257827
references.citation: Biochem Soc Trans. 2006 Dec;34(Pt 6):1124-7
references.pmid: 17073766
references.citation: J Nanobiotechnology. 2011 Sep 19;9:40
references.pmid: 21929751
references.citation: Mol Cancer Res. 2010 Apr;8(4):529-38
references.pmid: 20353999
references.citation: Nucleic Acids Res. 2012 Aug;40(15):7291-302
references.pmid: 22638581
references.citation: PLoS One. 2012;7(9):e45825
references.pmid: 23029264
references.citation: J Biol Chem. 2009 Feb 27;284(9):5546-56
references.pmid: 19106092
references.citation: Cancer Res. 2000 Mar 15;60(6):1536-40
references.pmid: 10749119
references.citation: PLoS One. 2012;7(3):e32571
references.pmid: 22396777
references.citation: Clin Cancer Res. 2012 Feb 1;18(3):726-36
references.pmid: 22298898
references.citation: Int J Cancer. 2012 Sep 15;131(6):1297-306
references.pmid: 22131072
references.citation: Immunity. 2008 May;28(5):630-8
references.pmid: 18455451
references.citation: Genes Chromosomes Cancer. 2011 Jul;50(7):499-509
references.pmid: 21472816
references.citation: Nat Med. 2008 Nov;14(11):1271-7
references.pmid: 18931683
references.citation: Mol Cancer Ther. 2012 Jan;11(1):244-53
references.pmid: 22057916
references.citation: Int J Clin Exp Pathol. 2009;2(4):361-9
references.pmid: 19158933
references.citation: Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4938-43
references.pmid: 21383160
references.citation: PLoS One. 2012;7(6):e38562
references.pmid: 22701667
references.citation: Am J Cancer Res. 2011;1(5):604-17
references.pmid: 21994901
references.citation: Cell. 2009 Jun 12;137(6):1032-46
references.pmid: 19524507
references.citation: Blood. 2012 Mar 1;119(9):2110-3
references.pmid: 22234685
references.citation: J Biol Chem. 2011 May 20;286(20):17796-808
references.pmid: 21454491
references.citation: Cell Death Differ. 2012 Feb;19(2):232-44
references.pmid: 21720384
references.citation: PLoS One. 2011;6(9):e24584
references.pmid: 21931765
references.citation: Int J Cancer. 2012 Dec 1;131(11):2668-77
references.pmid: 22438124
references.citation: Mol Cell Biol. 2005 Feb;25(4):1425-36
references.pmid: 15684393
references.citation: Carcinogenesis. 2012 Mar;33(3):501-8
references.pmid: 22180573
references.citation: Carcinogenesis. 2013 Jan;34(1):211-9
references.pmid: 23087084
references.citation: Prostate. 2012 Jun 15;72(9):1035-44
references.pmid: 22095517
references.citation: Mutat Res. 1985 Sep;151(2):263-8
references.pmid: 4033679
references.citation: Clin Chem. 2013 Jan;59(1):261-9
references.pmid: 23136246
references.citation: Oral Oncol. 2010 Apr;46(4):317-22
references.pmid: 20219416
references.citation: Liver Int. 2012 May;32(5):752-60
references.pmid: 22276989
references.citation: Blood. 2012 May 3;119(18):4253-63
references.pmid: 22411871
references.citation: Cell. 2009 Dec 11;139(6):1069-83
references.pmid: 19962179
references.citation: Hum Mol Genet. 2012 Jul 1;21(13):2991-3000
references.pmid: 22498974
references.citation: Stem Cells. 2009 Dec;27(12):3093-102
references.pmid: 19816956
references.citation: Am J Transl Res. 2012;4(4):432-42
references.pmid: 23145211
references.citation: Cancer Res. 2012 Jul 1;72(13):3393-404
references.pmid: 22719071
references.citation: Biochem J. 2008 Dec 15;416(3):453-62
references.pmid: 18651839
references.citation: Nat Genet. 2010 Aug;42(8):668-75
references.pmid: 20601956
references.citation: Nat Commun. 2011 Nov 22;2:554
references.pmid: 22109528
references.citation: PLoS One. 2012;7(10):e46697
references.pmid: 23071615
references.citation: J Pathol. 2012 Jul;227(3):336-45
references.pmid: 22431170